Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06056154 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety and Efficacy of the Hydrophobic Intraocular Lens Asqelio Monofocal With Biaspheric Design

StatusEnrolling by Invitation
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 8, 2024 (before its estimated May 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Enrolling by Invitationv4 Show 5 more changesShow less
    • Primary completion date: Dec 2023 to May 2025
    • Study completion date: Dec 2023 to Jul 2025
    • Start date changed from estimate of Oct 2023 to Jan 17, 2024
    • Site contact updated
    • Study title revised
  2. Lead sponsor: OFTALVIST (Oftalmología Vistahermosa S.L) to AST Products, Inc.v3
  3. Primary endpoints: 2 to 3
    • Start date: Sep 2023 to Oct 2023
    • Secondary endpoints: 2 to 3
    • Study title revised
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this observational study is to learn about the Asqelio monofocal intraocular lens (IOL) model QLIO130C in patients undergoing cataract surgery. The aim of the study is to evaluate the lens implementation safety and efficacy after at least 24 months.
Trial Details
NCT Number NCT06056154
Lead Sponsor AST Products, Inc.
Conditions
(from sponsor)		 Cataract, Pseudophakia
Related terms Cataract, Pseudophakia
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov